Table 1.
Variable | n (%)/median (IQR) | |
---|---|---|
Age | 26.0 (19.0-37.0) | |
Gender | ||
Male | 44 (80.0) | |
Female | 11 (20.0) | |
Affected eye(s) | ||
Unilateral | 47 (85.5) | |
Bilateral | 8 (14.5) | |
Etiology | ||
Neoplasm | 5 (9.1) | |
Trauma | 42 (76.4) | |
Viral | 1 (1.8) | |
Idiopathic | 4 (7.3) | |
Vasculopathy | 3 (5.5) | |
Management | ||
Surgery with botulinum toxin | 22 (40.0) | |
Surgery without botulinum toxin | 33 (60.0) | |
Type of surgery | ||
Vertical SR + IR transposition | 19 (34.5) | |
Vertical SR + IR transposition and MR recession | 6 (10.9) | |
MR recession and LR resection | 18 (32.7) | |
SR transposition + MR recession | 5 (9.1) | |
MR recession | 2 (3.6) | |
BMR recession | 5 (9.1) | |
Type of vertical transposition | ||
Hummelsheim | 9 (16.4) | |
Full tendon | 21 (38.2) | |
Foster suture | ||
Yes | 15 (27.2) | |
No | 40 (72.8) | |
Second surgery indicated | ||
Yes | 6 (10.9) | |
No | 49 (89.1) |
IQR: Interquartile range, SR: Superior rectus, IR: Inferior rectus, MR: Medial rectus, LR: Lateral rectus, BMR: Bilateral medial rectus